Cite Filings / ADMA / 0001140361-26-005877

Feed Companies Filings Check

Sign in

144

Sale of Securities

ADMA BIOLOGICS, INC. Filed 2026-02-17 Acc 0001140361-26-005877

Documents 1

144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

2026-03-09 144 Sale of Securities
2026-02-17 4 President and CEO sold 21,000 shares at $16.08 ($337,680)
2026-02-17 144 Sale of Securities
2026-02-12 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-02-11 4 Director acquired 10,690 shares (grant or award)
2026-02-11 4 COO and SVP, Compliance acquired 91,631 shares (grant or award)
2025-10-24 144 Sale of Securities

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…